Natixis Advisors LLC lifted its holdings in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 17.2% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 358,563 shares of the company's stock after purchasing an additional 52,538 shares during the quarter. Natixis Advisors LLC's holdings in Colgate-Palmolive were worth $33,597,000 as of its most recent filing with the SEC.
Other hedge funds have also made changes to their positions in the company. Brighton Jones LLC raised its holdings in Colgate-Palmolive by 4.4% in the fourth quarter. Brighton Jones LLC now owns 10,578 shares of the company's stock valued at $962,000 after acquiring an additional 450 shares in the last quarter. Bernard Wealth Management Corp. purchased a new position in Colgate-Palmolive in the fourth quarter valued at approximately $36,000. Meeder Advisory Services Inc. increased its stake in Colgate-Palmolive by 9.0% in the fourth quarter. Meeder Advisory Services Inc. now owns 20,483 shares of the company's stock valued at $1,862,000 after purchasing an additional 1,688 shares during the last quarter. RFG Bristol Wealth Advisors LLC purchased a new position in Colgate-Palmolive in the fourth quarter valued at approximately $289,000. Finally, Huntington National Bank increased its stake in Colgate-Palmolive by 3.4% in the fourth quarter. Huntington National Bank now owns 178,640 shares of the company's stock valued at $16,240,000 after purchasing an additional 5,811 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.
Analyst Ratings Changes
Several brokerages have commented on CL. Wells Fargo & Company dropped their price target on shares of Colgate-Palmolive from $88.00 to $83.00 and set an "underweight" rating on the stock in a research note on Monday. Barclays increased their price target on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an "equal weight" rating in a research note on Tuesday, July 15th. Morgan Stanley dropped their price target on shares of Colgate-Palmolive from $104.00 to $96.00 and set an "overweight" rating on the stock in a research note on Monday. Wall Street Zen lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research note on Wednesday, May 7th. Finally, UBS Group dropped their price target on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a research note on Thursday, July 17th. One analyst has rated the stock with a sell rating, five have issued a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $98.92.
Check Out Our Latest Research Report on Colgate-Palmolive
Colgate-Palmolive Stock Performance
NYSE:CL traded down $0.18 during midday trading on Monday, reaching $83.33. The stock had a trading volume of 5,486,553 shares, compared to its average volume of 5,273,744. The firm has a fifty day simple moving average of $89.59 and a two-hundred day simple moving average of $90.31. Colgate-Palmolive Company has a 12-month low of $82.40 and a 12-month high of $109.30. The company has a quick ratio of 0.28, a current ratio of 0.43 and a debt-to-equity ratio of 8.96. The stock has a market cap of $67.53 billion, a P/E ratio of 23.41, a P/E/G ratio of 4.31 and a beta of 0.35.
Colgate-Palmolive (NYSE:CL - Get Free Report) last released its earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%. The company had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter last year, the company earned $0.91 earnings per share. Colgate-Palmolive's quarterly revenue was up 1.0% compared to the same quarter last year. On average, equities analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.
Colgate-Palmolive Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be issued a $0.52 dividend. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.08 dividend on an annualized basis and a yield of 2.5%. Colgate-Palmolive's dividend payout ratio (DPR) is 58.76%.
Colgate-Palmolive Company Profile
(
Free Report)
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More

Before you consider Colgate-Palmolive, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colgate-Palmolive wasn't on the list.
While Colgate-Palmolive currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.